Iliac Venous Compression Clinical Trial
— VIDIOOfficial title:
Prospective, Single-arm, Multi-center, Pilot Study of IVUS Imaging Used as an Adjunct to Multiplanar Venography During Iliac-common Femoral Vein Assessment for Possible Endovascular Intervention
| Verified date | August 2016 |
| Source | Volcano Corporation |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Observational |
The purpose of this study is to demonstrate that IVUS identifies more instances of significant iliac and common femoral vein outflow obstruction than multiplanar venography.No hypothesis testing is planned.
| Status | Completed |
| Enrollment | 100 |
| Est. completion date | August 2016 |
| Est. primary completion date | February 2016 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - Subject must be > 18 and < 85 years of age - Willing to participate in and able to understand, read and sign the informed consent document before the planned procedure - CEAP clinical classification: C4, C5, or C6 (enrollment of C4 and C5 subjects will be capped at 50, such that at least 50 C6 subjects can be enrolled) - On duplex ultrasound: patent common femoral vein, and patent deep femoral vein, and/or femoral vein of the study leg - Undergoing iliofemoral and inferior vena caval venography with the intent to treat obstructive lesions Exclusion Criteria: - Subject cannot or will not provide written informed consent - Previous venous stent implantation involving the study leg or inferior vena cava - Previous venovenous bypass surgery involving the study leg - Known metal allergy precluding endovascular stent implantation - Known reaction or sensitivity to iodinated contrast that cannot be managed with premedication - Subjects who are pregnant (women of childbearing potential must have a negative pregnancy test within 7 days prior to enrollment - Severe, untreated (and readily treatable) superficial venous reflux (great saphenous vein >7 mm in diameter, and/or small saphenous vein >4 mm in diameter) - Acute deep venous thrombosis involving either leg - Known history of chronic total occlusion of the common femoral vein of the study leg. - Known history of thrombophilia (e.g., protein C or S deficiency, anti-thrombin III deficiency, presence of lupus anticoagulant, etc.) - Venous compression caused by tumor encasement - Venous outflow obstruction caused by tumor thrombus - Life expectancy of less than 6 months - Elevated baseline blood creatinine (value greater than the upper limit of the normal range) - Any concurrent disease or condition that, in the opinion of the Investigator, would make the subject unsuitable for participation in the study; examples include but are not limited to the inability to lie supine for the index procedure (e.g., severe congestive heart failure), thrombocytopenia or other hematological disorders associated with an unacceptable risk of bleeding, implanted orthopedic hardware that precludes proper imaging, etc. |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Italy | Hesperia Hospital | Modena | |
| Poland | Szpital Kliniczny Przemienienia Panskiego | Poznan | |
| United Kingdom | St Thomas Hospital | London | |
| United States | University of Alabama | Birmingham | Alabama |
| United States | Tufts Medical Center | Boston | Massachusetts |
| United States | Allegheny Vein and Vascular Clinic | Bradford | Pennsylvania |
| United States | Southern CT Vascular Center | Bridgeport | Connecticut |
| United States | University of North Carolina Hospital | Chapel Hill | North Carolina |
| United States | Vein Center of Southwest Louisiana/Imperial Health | Lake Charles | Louisiana |
| United States | The Mount Sinai Medical Center | New York | New York |
| United States | Norwalk Hospital | Norwalk | Connecticut |
| United States | Arizona Heart | Phoenix | Arizona |
| United States | Washington University School of Medicine | St Louis | Missouri |
| United States | SUNY Stony Brook University Medical Center | Stonybrook | New York |
| Lead Sponsor | Collaborator |
|---|---|
| Volcano Corporation |
United States, Italy, Poland, United Kingdom,
Alhalbouni S, Hingorani A, Shiferson A, Gopal K, Jung D, Novak D, Marks N, Ascher E. Iliac-femoral venous stenting for lower extremity venous stasis symptoms. Ann Vasc Surg. 2012 Feb;26(2):185-9. doi: 10.1016/j.avsg.2011.05.033. Epub 2011 Oct 22. — View Citation
Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. Minerva Cardioangiol. 2007 Aug;55(4):459-76. Review. English, Italian. — View Citation
Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 Dec;40(6):1248-52. Review. — View Citation
Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, Elamin MB, Duggirala MK, Erwin PJ, Montori VM, Gloviczki P. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011 May;53(5 Suppl):49S-65S. doi: 10.1016/j.jvs.2011.02.031. Review. — View Citation
Murphy EH, Broker HS, Johnson EJ, Modrall JG, Valentine RJ, Arko FR 3rd. Device and imaging-specific volumetric analysis of clot lysis after percutaneous mechanical thrombectomy for iliofemoral DVT. J Endovasc Ther. 2010 Jun;17(3):423-33. doi: 10.1583/10-3088.1. — View Citation
Neglén P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg. 2002 Apr;35(4):694-700. — View Citation
Raju S, Neglén P. Clinical practice. Chronic venous insufficiency and varicose veins. N Engl J Med. 2009 May 28;360(22):2319-27. doi: 10.1056/NEJMcp0802444. Review. — View Citation
Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg. 2006 Jul;44(1):136-43; discussion 144. — View Citation
Raju S. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013 Apr;57(4):1163-9. doi: 10.1016/j.jvs.2012.11.084. Epub 2013 Feb 20. Review. — View Citation
Stacey MC, Burnand KG, Layer GT, Pattison M, Browse NL. Measurement of the healing of venous ulcers. Aust N Z J Surg. 1991 Nov;61(11):844-8. — View Citation
Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, Meissner MH, Rutherford RB; American Venous Forum Ad Hoc Outcomes Working Group. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010 Nov;52(5):1387-96. doi: 10.1016/j.jvs.2010.06.161. Epub 2010 Sep 27. — View Citation
* Note: There are 11 references in all — Click here to view all references
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | 100 patients with Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP) classification C4-6 undergoing iliac and common femoral and venography with intention to treat venous outflow obstruction. | Primary Endpoints: Both venous IVUS and traditional venography will provide measurements of minimum and maximum diameter reduction due to iliofemoral venous obstruction/compression; cross-sectional area reduction will also be measured by IVUS, and calculated for venography (from min. and max. diameters, assuming elliptical cross-section6). The diameters and cross-sectional area are compared to adjacent reference vessel in order to calculate the degree of stenosis. The percentage of significant stenosis detected at various thresholds [e.g., 50%, 60%, 70%, 80%, for diameter reduction, and (separately) for area reduction] with each method will be compared in a pair-wise fashion. This will be done with descriptive statistics of the detection rates for each method, and the rate of discordance between the two. In addition to the binary outcome of significant stenosis, the numeric values for diameters and cross-sectional areas will be compared. | 6 month | No |